First Eagle Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,800
| Closed | -$8K | – | 323 |
|
|
2017
Q4 | $8K | Hold |
2,800
| – | – | ﹤0.01% | 308 |
|
|
2017
Q3 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 325 |
|
|
2017
Q2 | $7K | Hold |
2,800
| – | – | ﹤0.01% | 310 |
|
|
2017
Q1 | $6K | Hold |
2,800
| – | – | ﹤0.01% | 307 |
|
|
2016
Q4 | $6K | Hold |
2,800
| – | – | ﹤0.01% | 314 |
|
|
2016
Q3 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 328 |
|
|
2016
Q2 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 338 |
|
|
2016
Q1 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 320 |
|
|
2015
Q4 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 310 |
|
|
2015
Q3 | $14K | Hold |
2,800
| – | – | ﹤0.01% | 296 |
|
|
2015
Q2 | $18K | Hold |
2,800
| – | – | ﹤0.01% | 293 |
|
|
2015
Q1 | $20K | Hold |
2,800
| – | – | ﹤0.01% | 305 |
|
|
2014
Q4 | $22K | Hold |
2,800
| – | – | ﹤0.01% | 308 |
|
|
2014
Q3 | $21K | Hold |
2,800
| – | – | ﹤0.01% | 308 |
|
|
2014
Q2 | $27K | Hold |
2,800
| – | – | ﹤0.01% | 295 |
|
|
2014
Q1 | $23K | Hold |
2,800
| – | – | ﹤0.01% | 362 |
|
|
2013
Q4 | $24K | Hold |
2,800
| – | – | ﹤0.01% | 345 |
|
|
2013
Q3 | $22K | Hold |
2,800
| – | – | ﹤0.01% | 331 |
|
|
2013
Q2 | $22K | Buy |
+2,800
| New | +$22K | ﹤0.01% | 321 |
|